Altria Leaves Cannabis Investors Hanging

The tobacco giant’s latest report focused on a more controversial topic.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

This article was originally published on Fool.com

Tobacco giant Altria Group (NYSE:MO) has led its industry for decades, finding ways to keep profits rising even as cigarette smoking has become less popular. With interest in tobacco seemingly in a permanent state of decline, some investors think that marijuana would be a better market for Altria to pursue.

Coming into the company’s third-quarter financial report last week, Altria investors were hoping that the tobacco giant would still be able to deliver earnings growth despite the long-term trends among smokers. Altria succeeded on that front, but it remained relatively quiet about its plans for the cannabis market, instead taking steps to address more immediate concerns about e-cigarettes.

MarkTen XL marketing, with four rectangular packages in different colors against a black background

IMAGE SOURCE: ALTRIA.

How Altria did

Altria’s third-quarter results marked a good rebound from a poor showing three months ago. Revenue net of excise tax climbed 3.3% to $5.29 billion, which was about $85 million more than most of those following the stock had expected to see. Net income was up 4% to $1.94 billion, and the resulting adjusted earnings of $1.08 per share came in just above the consensus forecast among investors for $1.07 per share on the bottom line.

From a segment perspective, Altria’s results were reasonably solid across the board. Revenue from the key smokeable products segment, which includes the Marlboro cigarette division, rose 2.7% from year-earlier levels. That came despite substantial declines in cigarette shipment volumes, which were down 3.7% from the third quarter of 2017. That combination left the unit’s operating company income roughly unchanged over the period, and margin levels were down due to higher costs that were offset by higher selling prices. Market share overall fell half a percentage point to 50.1%.

Altria’s smokeless products division did better. Revenue net of excise tax jumped more than 7%, and adjusted operating company income rose by the same 7% figure, as higher pricing was more than enough to overcome rising expenses. Shipment volume inched higher by 0.4%, and once again, the key Copenhagen brand led the way for the segment.

Altria’s wine business was weaker. Revenue was mostly flat, and operating company income fell nearly 20% despite a 2.4% rise in wine shipment volume. Higher costs included some one-time employee bonuses that represented a substantial amount of the small division’s overall profit.

What’s ahead for Altria?

CEO Howard Willard was enthusiastic about the company’s performance. “Altria delivered excellent third-quarter adjusted diluted earnings-per-share growth of 20%,” Willard said, “and continued to return large amounts of cash to our shareholders.” The CEO noted that Altria’s tobacco business is solid, and the company is “making strategic investments to drive long-term success.” Those sentiments led Altria to boost its guidance very slightly, lifting the bottom end of its projected earnings range by $0.01 to set a new range of $3.95 to $4.03 per share.

Yet on the marijuana front, Altria didn’t say much. Willard’s comments were limited to the following:

We are exploring opportunities in the category, and we acknowledge that it is currently federally illegal in the U.S., but we think it’s worth exploring the category because that might change in the future. I’ll hold back on explaining in more detail kind of how we view the category, because we’re relatively early in our exploration.

Instead, Altria discussed plans to respond to the U.S. Food and Drug Administration’s concerns about electronic cigarettes. Altria’s Nu Mark subsidiary will remove the pod-based Elite and Apex products until the FDA issues a market order. For remaining products under the MarkTen and Green Smoke brands, Nu Mark will keep selling tobacco, menthol, and mint varieties, but discontinue all other flavors until it gets FDA approval or it can address concerns about youth use of the products. The move will put pressure on Altria’s competitors, especially those for which e-cigarettes make up their primary business.

Altria shareholders were generally pleased with the report, sending the stock up between 1% and 2% after its release. Although marijuana investors will have to wait a while longer to find out the tobacco giant’s cannabis plans, solid financial performance shows that Altria is doing a good job of keeping pace with its historical track record despite ever-present headwinds.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Dan Caplinger has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing Articles

Investing Articles

How much does an investor need in a Stocks and Shares ISA to earn £1,000 a month in passive income?

A Stocks and Shares ISA's a valuable asset for investors. Not having to pay dividend tax can be a big…

Read more »

Investing Articles

9% dividend yield! Could buying this FTSE 250 stock earn me massive passive income?

Assura looks like an outstanding stock for dividend investors to consider. But is the 9% dividend yield the passive income…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Why I think this month could be critical for the Lloyds share price!

Our writer explains why he thinks the bank's 2024 results will have a significant impact on the short-term direction of…

Read more »

British Pennies on a Pound Note
Investing Articles

This former penny share has soared 168%. Is the best yet to come?

When Christopher Ruane saw a penny share as a potential bargain last year, he was spot on. So having not…

Read more »

Mature couple at the beach
Investing Articles

£20k in an ISA? Here’s how it could generate £1 of passive income every hour — forever

With a long-term approach, Christopher Ruane explains how an investor could aim to earn a pound per hour in passive…

Read more »

One English pound placed on a graph to represent an economic down turn
Investing Articles

FTSE shares: overpriced or still a bargain?

Christopher Ruane reckons a storming FTSE 100 performance of late doesn't tell us much about whether there are still possible…

Read more »

Blue NIO sports car in Oslo showroom
Investing Articles

Would an investor have made money investing £2k in NIO stock 5 years ago?

Our writer looks at how NIO stock has performed over recent years and weighs the bull and bear cases as…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

5 steps to start buying shares with £5 a day

In a handful of steps, our writer explains how someone new to the stock market could start buying shares for…

Read more »